van den Bent MJ - Search Results

1

Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma.

van den Bent MJ. van den Bent MJ. Neuro Oncol. 2014 Dec;16(12):1570-4. doi: 10.1093/neuonc/nou297. Epub 2014 Oct 29. Neuro Oncol. 2014. PMID: 25355680 Free PMC article. Review.

2

The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor.

Straathof CS, van den Bent MJ, Ma J, Schmitz PI, Kros JM, Stoter G, Vecht CJ, Schellens JH. Straathof CS, et al. Among authors: van den bent mj. J Neurooncol. 1998 Mar;37(1):1-8. doi: 10.1023/a:1005835212246. J Neurooncol. 1998. PMID: 9525832

3

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.

van den Bent MJ, Kros JM, Heimans JJ, Pronk LC, van Groeningen CJ, Krouwer HG, Taphoorn MJ, Zonnenberg BA, Tijssen CC, Twijnstra A, Punt CJ, Boogerd W. van den Bent MJ, et al. Among authors: van groeningen cj. Neurology. 1998 Oct;51(4):1140-5. doi: 10.1212/wnl.51.4.1140. Neurology. 1998. PMID: 9781544

4

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas.

van den Bent MJ, Schellens JH, Vecht CJ, Sillevis Smit PA, Loosveld OJ, Ma J, Tijssen CC, Jansen RL, Kros JM, Verweij J. van den Bent MJ, et al. Eur J Cancer. 1998 Sep;34(10):1570-4. doi: 10.1016/s0959-8049(98)00138-5. Eur J Cancer. 1998. PMID: 9893630 Clinical Trial.

5

The accumulation of topotecan in 9L glioma and in brain parenchyma with and without dexamethasone administration.

Straathof CS, van den Bent MJ, Loos WJ, Vecht CJ, Schellens JH. Straathof CS, et al. Among authors: van den bent mj. J Neurooncol. 1999 Apr;42(2):117-22. doi: 10.1023/a:1006166716683. J Neurooncol. 1999. PMID: 10421068

6

Chemotherapy in adult malignant glioma.

van den Bent MJ. van den Bent MJ. Front Radiat Ther Oncol. 1999;33:174-91. doi: 10.1159/000061234. Front Radiat Ther Oncol. 1999. PMID: 10549488 Review. No abstract available.

7

Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma.

van den Bent MJ, Pronk L, Sillevis Smitt PA, Vecht CJ, Eskens FA, Verweij J. van den Bent MJ, et al. J Neurooncol. 1999 Aug;44(1):59-64. doi: 10.1023/a:1006201909435. J Neurooncol. 1999. PMID: 10582670 Clinical Trial.

8

Chemotherapy of oligodendroglial tumours: current developments.

van den Bent MJ. van den Bent MJ. Forum (Genova). 2000 Apr-Jun;10(2):108-18. Forum (Genova). 2000. PMID: 10875973 Review.

9

PCV chemotherapy for recurrent glioblastoma multiforme.

Kappelle AC, Postma TJ, Taphoorn MJ, Groeneveld GJ, van den Bent MJ, van Groeningen CJ, Zonnenberg BA, Sneeuw KC, Heimans JJ. Kappelle AC, et al. Among authors: van groeningen cj, van den bent mj. Neurology. 2001 Jan 9;56(1):118-20. doi: 10.1212/wnl.56.1.118. Neurology. 2001. PMID: 11148250

10

New perspectives for the diagnosis and treatment of oligodendroglioma.

van den Bent MJ. van den Bent MJ. Expert Rev Anticancer Ther. 2001 Oct;1(3):348-56. doi: 10.1586/14737140.1.3.348. Expert Rev Anticancer Ther. 2001. PMID: 12113102 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

519 results

Search Page